Browse by author
Lookup NU author(s): Dr Ian HardcastleORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Antiestrogens are widely used in the treatment of hormone dependent breast cancer. Their principle mechanism of action is believed to be the displacement of the growth promoting hormone estrogen from its protein receptor. Many antiestrogens also exhibit hormone independent effects, such as antagonism of the calcium binding protein calmodulin, which may contribute to their therapeutic potential.Calmodulin is essential to many cellular processes including the functioning of the estrogen receptor. The possibility that a combined antiestrogen - calmodulin antagonist would be useful for cancer therapy has led to the development of antiestrogens which are potent calmodulin antagonists.This review describes the structure - activity relationships for calmodulin antagonists, the rational design of such compounds and their biological properties. The synthetic methodology for some of these antiestrogens will also be discussed.
Author(s): Hardcastle IR, Rowlands MG, Jarman M
Publication type: Article
Publication status: Published
Journal: Current Medicinal Chemistry
Year: 1996
Volume: 3
Issue: 3
Pages: 211-226
ISSN (print): 0929-8673
ISSN (electronic): 1875-533X
Publisher: Bentham Science Publishers Ltd.
URL: http://www.bentham.org/cmc/contabs/vol3-3.html
